Brain in Hand Leadership
Our team consists of neurodivergent and neurotypical professionals with backgrounds in health and social care, psychology, research, technology, business, and education; every member of our team is committed to making our vision a reality.
Brain in Hand’s Senior Leadership Team is responsible for ensuring that each area of the business runs smoothly and contributes to the big picture. Our leadership team is supported by a board of executive and non-executive directors with a wealth of experience across multiple sectors and industries.
Louise Morpeth, Chief Executive Officer and Board Member
Louise has over 20 years experience of senior leadership roles in the voluntary sector developing and testing innovations to improve user outcomes. She joined Brain in Hand in 2018 as Head of R&D and became Chief Exec in 2019.
Until 2017, she was Chief Exec of the Dartington Social Research Unit, a national research charity that brought evidence to bear on policy and practice. Louise was awarded a PhD by Exeter University in 2003.
Glenn Atter, Chief Technical Officer
Glenn is a technologist with over 20 years of commercial software development.
In his role as CTO, Glenn has taken the technology of Brain in Hand from initial prototype to fully fledged solution. He is keen to drive technology for supporting mental health in the same way that it has improved physical health.
Mat Taylor, Commercial Director
Mat is a commercial leader, with a 15 year track record in senior leadership roles delivered both domestically and internationally for Health and Social Care technology businesses.
He is passionate about driving wide scale adoption of technologies that can help users achieve positive outcomes.
Amy Cox, Finance Director
Amy, a qualified accountant, joined Brain in Hand in August 2021 as Finance Director. She has over 15 years experience in senior finance roles in a wide variety of industries within the private sector.
Amy is delighted to be part of the team driving significant user impact through use of the Brain in Hand system.
Matthew Arnold, Head of Product
Matthew has worked in product development in start-ups over the past 8 years. He leads Product and Development at Brain in Hand and is focussed on creating a delightful, impactful, and scalable user experience.
He’s passionate about how technology and design can enable positive behavioural change.
Sarah Todd, Service Delivery Director
Sarah has devoted her career to improving the academic, personal, and professional lives of individuals from diverse and underrepresented groups. She and her team are proud to play a key part in supporting users to thrive in their neurodiversity and achieve their full potential.
Tamsin Fielden, Marketing Director
Tamsin has over 25 years marketing experience across consumer brands (Unilever, Colgate-Palmolive), health and medical devices (Senior Level international), SMEs, and public sector.
She has extensive experience with digital and technology brands and a passion for social change, and is an NLP and mindset coach.
The Brain in Hand Board
David Fry, Executive Board Director
Starting his career at PwC, David has been a director of several healthcare companies and was Brain in Hand’s CEO from 2013 to 2019. David now works closely with our CEO, continuing to lend his experience and wisdom to Brain in Hand’s leadership, and is responsible for investment and major commercial matters.
Steve Page, Non-Executive Chairman
Steve has had a successful career as CEO of Oxleas NHS Foundation Trust, a large mental health and community services trust in South London, and as an independent Chair or non-executive director to a number of companies providing innovative and quality services.
Marek Gumienny, Non-Executive Director
Marek has substantial experience in private equity, during which time he has successfully invested in and exited a range of companies across many sectors, geographies and economic cycles. He is a founder member of 24 Haymarket Group.
Emma Rooth, Non-Executive Director
Emma Rooth is Managing Director of Torbay Pharmaceuticals, and a non-executive director of the UK Biocentre. She was a non-executive director of Thera Trust for over four years; prior to that, she was at AAH Pharmaceuticals for eleven years, then at BUPA as Commercial Director for the Public Sector business.
Emma brings a wealth of knowledge and experience of working across the Life Sciences and Health Care sectors in the UK and internationally. She has four years’ experience as a consultant in Healthcare and Medtech sectors, working for PE-backed businesses.